ClearPoint Neuro, Inc. (CLPT) research
ClearPoint Neuro, Inc.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $15.79
- As of
ClearPoint Neuro, Inc. (CLPT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-03.
As of . Source: SEC EDGAR filings for CLPT. Method and limitations.
Share the CLPT intelligence card
See CLPT live in the terminal
Track CLPT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live CLPT terminal, freeActive signals for CLPT
- highCONSENSUS_BUY
3 tracked funds increased CLPT this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +54% to CLPT (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 77% of CLPT (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +65% to CLPT (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 77% of CLPT (2026Q2)
FREE, NO ACCOUNT
Every signal on CLPT, as it fires
You are seeing 5 of 17 signals recorded on CLPT since 2026-05-31.
The five above landed across 2 days. The other 12 were recorded on 5 other days. 12 of the 17 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in CLPT (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 18507C103 · 2026Q2 | $6.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 18507C103 · 2026Q2 | $2.8M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 18507C103 · 2026Q2 | $869K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CLPT
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
CLPT against its peers
CLPT's operating margin of -65.4% ranks in the 25th percentile of 21 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-06-30.
| Metric | CLPT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 37.0M USD | 100.0M USD | 11 | 21 |
| Gross margin | 61.4% | 74.5% | 40 | 20 |
| Operating margin | -65.4% | -19.3% | 25 | 21 |
| Net margin | -69.1% | -21.5% | 20 | 21 |
| Return on equity | -91.1% | -19.1% | 21 | 20 |
| P / E | n/a | 24.2x | n/a | 5 |
Peers (22): MASS, NPCE, CV, OFIX, TCMD, SENS, VMD, CATX, DCTH, KIDS, TLSI, RCEL, LAB, TMCI, SSII, INFU, QDEL, STIM, ELMD, SIBN, INMD, CBLL. Left out: MOBI (no annual filing), BWAY (period gap), PROF (no annual filing). Fiscal periods ending between 2025-12-28 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CLPT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more CLPT signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to CLPTand get the insider, 13F, options, and confluence read in one view.